Role of micrornas in diagnosis, prognosis and management of multiple myeloma

Amro M. Soliman, Teoh Seong Lin*, Pasuk Mahakkanukrauh, Srijit Das*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

12 Citations (Scopus)


Multiple myeloma (MM) is a cancerous bone disease characterized by malignant transformation of plasma cells in the bone marrow. MM is considered to be the second most common blood malignancy, with 20,000 new cases reported every year in the USA. Extensive research is currently enduring to validate diagnostic and therapeutic means to manage MM. microRNAs (miRNAs) were shown to be dysregulated in MM cases and to have a potential role in either progression or suppression of MM. Therefore, researchers investigated miRNAs levels in MM plasma cells and created tools to test their impact on tumor growth. In the present review, we discuss the most recently discovered miRNAs and their regulation in MM. Furthermore, we emphasized utilizing miRNAs as potential targets in the diagnosis, prognosis and treatment of MM, which can be useful for future clinical management.

Original languageEnglish
Article number7539
Pages (from-to)1-22
Number of pages22
JournalInternational Journal of Molecular Sciences
Issue number20
Publication statusPublished - Oct 2 2020


  • Cancer
  • Diagnostic marker
  • MiRNA
  • Multiple myeloma
  • OncomiR
  • Tumor suppressor

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry


Dive into the research topics of 'Role of micrornas in diagnosis, prognosis and management of multiple myeloma'. Together they form a unique fingerprint.

Cite this